Mereo BioPharma Group plc American Depositary Shares

MREO XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

46M

Short interest (Jul 15)

2.2%

Net Short (Jul 27 ): 0.0%

Borrow Fee

3.26%

↑ 5.1%

Available Shares

↑ 5.7%

Price Chart

Company Overview

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001719714

Asset Type: ADRC

Market Data

Market Cap: $45,938,235

Employees: 39

Status: Active

Short Interest

Current Borrow Fee 3.26%

Range: 3.26% - 3.26%

Available Shares 7M

Range: 6.1M - 7.1M

Recent Changes

Fee Change: ↓ 10.4%

Available Change: ↓ 16.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime